GATA-3 and c-Myb are core elements of a transcriptionally active complex essential for human Th2 cell development and maintenance. We report herein, mechanistic details concerning the role of these transcription factors in human peripheral blood Th2 cell development. Silencing c-Myb in normal human naive CD4+ cells under Th2 cell promoting conditions blocked upregulation of GATA-3 and IL-4, and in effector/memory CD4+ T cells, decreased expression of GATA-3 and Th2 cytokines. In primary T cells, c-Myb allows GATA-3 to auto-activate its own expression, an event that requires the direct interaction of c-Myb and GATA-3 on their respective binding sites in GATA-3's promoter. Immunoprecipitation revealed that the c-Myb/GATA-3 complex contained Menin, and MLL. MLL recruitment into the c-Myb-GATA-3-Menin complex was associated with the formation Th2 memory cells. That MLL driven epigenetic changes was mechanistically important for this transition was suggested by the fact that silencing c-Myb significantly decreased the methylation of histone H3K4 and the acetylation of histone H3K9 at the GATA-3 locus in developing Th2 and CD4+ effector/memory cells.
Introduction
T helper cells play a central role in immune responses. They are a heterogeneous group of cells which are further classified into three main subsets, Th1, Th2 and Th17, based on their cytokine production profiles, and effector functions 1 . Th1 cells produce IFN-γ and TNF, and regulate cell-mediated immune responses to intracellular pathogens. Th2 cells produce IL-4, IL-5, and IL-13, which are essential for the generation of antibodies and elimination of extracellular pathogens. Th17 cells comprise a recently identified Th subpopulation that appears to play an essential role in protection against certain extracellular pathogens such as K. pneumoniae, and in the pathogenesis of autoimmunity 2 . Some of the transcription factors which govern Th1/Th2/Th17 cell fate decisions have been identified, and of these, GATA-3 and T-bet appear to be the key regulators of Th2 and Th1 cell development, respectively 3, 4 .
GATA-3 is a member of the zinc finger transcription factor family 5 . In addition to its prominent role in regulating Th2 cell differentiation, it also essential for thymic T cell development 6, 7 . In peripheral blood helper T cells, IL-4 mediated activation of STAT6 induces GATA-3 mRNA expression, an early event in Th2 cell differentiation. Interestingly, ectopic expression of a small amount of GATA-3 can induce robust expression of endogenous GATA-3, independent of IL-4 signaling and STAT6 activation [8] [9] [10] [11] suggesting the presence of an IL-4/STAT6 independent auto-regulatory feedback loop. As GATA-3 levels rise, the cells commit to Th2 development, and begin to acquire the Th2 phenotype, all at the expense of Th1 cell development 5 . The mechanistic details of how GATA-3 expression is regulated during Th2 cell development, and how it apparently primes its own expression have not been fully elucidated. Here, we report that c-Myb, a transcription factor previously reported to play a direct role in the regulation of GATA-For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From 3 expression 12 , plays an essential role in assembling a transcriptional complex composed of GATA-3, Menin, and Myb that allows GATA-3 to auto-regulate its own expression. These studies provide a more detailed, mechanisms oriented explanation for c-Myb's pivotal role in allowing GATA-3 to regulate the development, and maintain viability, of Th2 cells in peripheral blood.
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Materials and Methods

Lymphocyte preparation and cell culture
Normal human peripheral blood CD4+ T lymphocytes were obtained from consenting donors via the Human Immunology Core Facility at the University of Pennsylvania School of Medicine.
Naive and memory/effector cells were sorted by CD45RO or CD45RA MicroBeads (Miltenyi Biotec), or PE-anti-human CD45RA antibody (BD Biosciences). Freshly isolated cells were cultured in RPMI-1640 medium supplemented with 10% FCS. Naive CD4+ T cells were cultured with IL-12 (10 ng/ml), IL-2 (20 ng/ml) and anti-IL-4 antibody (10 μg/ml) or with IL-4 (25-40 ng/ml), IL-2 (20 ng/ml) and anti-IL-12 antibody (5-10 μg/ml) to promote respectively Th1 or Th2 cell formation in 3-10 days. CD3/CD28 antibodies (Dynabeads CD3/CD28 T-cell expander, Invitrogen) were used for every primary T cell stimulation. Jurkat and 293T cells were cultured in RPMI-1640 or DMEM medium supplemented with 10% FCS, respectively.
Lentivirus vector construct for c-myb RNAi
c-myb-1(tgttattgccaagcactta), c-myb-3 (ctgcctggacgaactgata) and control c-myb-1 scramble (ctttatacgtagtcataag) siRNA sequences were inserted into the H1UG lentivirus vector (a gift of Dr. E.J. Brown, University of Pennsylvania) which was modified from FUGW vector 13 . The mixed lentivirus constructs expressing c-myb-1 and c-myb-3 shRNA were transduced into human primary CD4+ T cells (details provided in Supplemental Methods, and Figure S1 ).
Dual-Luciferase reporter assay
Six reporter constructs were prepared by inserting the human GATA-3 promoter into pGL3 (Promega). pG3P-L: -2039 to +587 relative to the transcription start site, pG3P-S: -148 to For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From +587bp, and pG3P-M: -148 to +587 contained one mutated myb binding site as illustrated in Figure 2C , pG3P-GBmut1 and 2: -148 to +587 with mutated GATA-3 binding site as described in the results section. The pcDNA3 vectors containing full length c-myb (1-5 µg) and/or full length GATA-3 (1-5 µg) were co-transfected with phRL (0.01-0.02 µg) and appropriate promoter upstream of luciferase in pGL3 (0.5-1.0 µg) into human primary T cells using Human T cell Nucleofector kit (Lonza) or into 293T cells using Lipofectamine 2000 (Invitrogen).
Firefly and Renilla luciferase activities were measured with a Dual-Luciferase reporter assay kit (Promega) using a luminometer.
Immunoprecipitation
Primary CD4+ T cell lysates were prepared in a buffer containing 0.5% CA630, 50mM Tris ( pH7.5), 150mM NaCl, and protease inhibitor cocktails (complete mini, Roche) and equal volumes of the extract were incubated with 4 μg of the respective antibody with gentle rotation overnight at 4 °C. Wild-type c-Myb, c-Myb-Flag tag, wild-type GATA-3, GATA-3 Flag-tag, 325-truncated c-Myb with Flag-tag and Menin proteins were in vitro translated from their respective pcDNA expression vector using TNT Quick Coupled Transcription/Translation Systems (Promega). These proteins in the above were incubated with the same amount of anti-Flag M2-agarose (Sigma) with gentle rotation for 4 hours at 4 °C.
Chromatin immunoprecipitation (ChIP) and Re-ChIP assay
ChIP assays were completed using a ChIP Assay kit (Millipore) as previously described 14 . CD4+ naive or effector/memory T cells were cultured under Th1 or Th2 conditions for 3-5 days except where noted (see below). The cells were re-stimulated with IL-4 and IL-2 at 6 hours before For personal use only. on November 16, 2017. by guest www.bloodjournal.org From crosslinking with formaldhyde. Imunoprecipitation was performed with anti-c-Myb (clone 1-1; Millipore), anti-GATA-3 (a mixture of MAB2605; R&D Systems and HG3-31; Santa Cruz), anti p300 (clone RW128, Millipore), anti-CBP (Bethyl), anti-MLL1 (Bethyl), anti-Menin (Bethyl), and anti-Flag M2 (Sigma) antibodies. The precipitated DNA fractions was then amplified by quantitative real time PCR using standard protocols with Sybr green and GATA-3 downstream or upstream promoter specific primers (forward: 5'-GGGTTTGGGTTGCAGTTTCCTTGT -3'; reverse: 5'-GCGACGCAACTTAAGGAGGTTCTA -3' or forward: 5'-CGCCAGATCTGTCAGTTTCA -3'; reverse: 5'-AGGAGAAACAGCGAGGGAAT -3', respectively). Re-ChIP assays were completed using Re-ChIP-IT, Magnetic Chromatin Re-Immunoprecipitation Kit according to the instruction manual (Active Motif). In ChIP assays for histone modification, CD4+ naive and effector/memory T cells were stimulated under Th2 promoting conditions for 7 and 4 days respectively. Antibodies against di-and tri-methylated H3K4 (ab6000), acetyl K9 (ab4441) and di-methyl K9 (ab1220) (Abcam, Cambridge, MA) were utilized for the ChIP assays probing the GATA-3 locus in primary CD4+ T cells and Jurkat cells (see experimental details in supplementary methods).
Statistical analyses
Statistical comparisons of the data were completed using the two-tailed Student's t test. The level of significance was set at P values of <0.05 in all cases.
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Results
Silencing c-Myb decreases GATA-3 and Th2 cytokines gene expression in primary human
Th2 cells.
c-Myb expression is very high in immature hematopoietic cells and is down regulated during terminal differentiation 15, 16 . In peripheral blood, naive and effector/memory T lymphocytes express c-Myb expression at low level. However, after stimulation with a combination of IL-2, anti-CD3 and anti-CD28 antibodies, c-Myb expression in naive and effector/memory T cells increases dramatically. The biological significance of this increase is still unclear. Therefore, to begin to understand the ramifications of this observation, a short hairpin RNA (shRNA) was employed to silence c-Myb expression in human peripheral effector/memory CD4+ T cells after stimulation with anti-CD3/CD28 antibodies and IL-2. This strategy yielded a sequence specific, 85% knockdown of c-Myb expression (Supplementary Figure S2 ). Effects on candidate downstream gene targets of c-Myb were screened using a RT² Profiler™ PCR Array Human Th1-Th2-Th3 (SABiosciences). Of the 84 genes represented on the array ( Supplementary Table   S1 ), the largest changes were noted in GATA-3, and in the expression of Th2 cytokine genes, a result which was confirmed by re-screening the original cell populations using quantitative real time PCR (QRT-PCR).
After initial screening by PCR array and QRT-PCR, we next determined whether c-Myb contributes to human Th2 cell development, and maintenance, from naive CD4+ T cells using the same c-Myb silencing strategy. Before transduction with lentiviral vectors, human primary CD4+ T cells were stimulated with anti-CD3/CD28 antibodies for 16 hours, followed by IL-2 for 5 hours. Post-transduction, the cells were sorted to isolate CD4+CD45RO-(naive) and
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From CD4+CD45RO+ (effector/memory) T cells, which were then stimulated under Th1 or Th2 cell promoting conditions. Naive human peripheral blood CD4+ T cells expressing the c-myb shRNA, demonstrated 90% and 73% less up-regulation of GATA-3 and IL-4 mRNA, respectively, compared to cells expressing control shRNA, when cultured under Th2 cell promoting conditions ( Figure 1A) . Flow cytometric analysis also showed that intracellular IL-4 expression was diminished in CD4+ cells stimulated under Th2 promoting conditions ( Figure   1B ). In contrast, silencing c-Myb did not decrease T-bet mRNA expression, or IFN-γ expression in cells induced to undergo Th1 cell formation ( Figure 1A ).
In primary effector/memory CD4+ T cells, which includes established Th2 cells, c-Myb suppression with shRNA also decreased GATA-3 mRNA expression by approximately 85%, while the suppression of IL-4 expression was only ~50% ( Figure 1C ). Other Th2 cytokines, IL-5 and IL-13 decreased significantly as well, while T-bet and IFN-γ mRNA expression did not change. In toto, these results suggest that c-Myb not only exerts important functions during Th2 cell development but that it also plays a role in the maintenance of established Th2 cells. A more mechanisms based understanding of these observations was then sought by carrying out the next series of experiments.
c-Myb activates GATA-3 expression by binding to a canonical site within the GATA-3 exon 1b promoter in naive CD4 T cells under Th2 cell promoting conditions.
Two different promoters are known to regulate GATA-3 expression 17 (Figure 2A ). Recent papers have shown that the GATA-3 exon 1a promoter is a direct target for Notch signaling, and is critical for GATA-3 expression 18, 19 . To investigate the possibility that c-Myb might also play For personal use only. on November 16, 2017. by guest www.bloodjournal.org From a direct role in regulating GATA-3 expression, we first measured the expression of mRNA transcribed from GATA-3 exon 1a and 1b, in human primary naive CD4+ cells stimulated under Th2 promoting conditions. On days 3 and 5 post stimulation, expression of GATA-3 exon 1b mRNA was dramatically increased while expression of exon 1a mRNA did not increase significantly ( Figure 2A ). In addition, exon 1b mRNA expression remained concordant with cmyb expression ( Figure 2A ). These results strongly suggested that in primary naive CD4+ T cells stimulated under Th2 promoting conditions exon 1b promoter was utilized preferentially and that c-Myb might therefore bind in this locus.
To test this hypothesis, we performed ChIP assays to determine if, and where, c-Myb bound to the GATA-3 promoter in primary human CD4 cells during Th-subset development. Naive CD4+ T cells were cultured under Th1 or Th2 cell promoting conditions for 3-5 days. A ChIP assay was then performed ( Figure 2B ) which revealed that in naive cells, the exon 1b promoter was utilized by c-Myb in cells stimulated under Th2 cell promoting conditions, but not under Th1 cell promoting conditions ( Figure 2B ). Interestingly, the GATA-3 exon 1a promoter preferred by Notch 18, 19 was not occupied by c-Myb under either Th1 or Th2 promoting conditions ( Figure   2B ). These results corroborate the mRNA expression data that suggested that c-Myb binds the downstream GATA-3 promoter under Th2 cell promoting conditions. We next sought to more precisely define the c-Myb binding site within the GATA-3 (exon 1b) promoter and took advantage of previously reported investigations to accomplish this task 20,21 .
For example, Gregoire et al analyzed a region in the human GATA-3 gene transcription initiation region from nts -8025 to +598 and showed that the -96/+598 DNA fragment is the GATA-3 minimal promoter 21 . The GATA-3 promoter region that includes the minimal promoter was highly conserved in mammals including human, mouse, rat, and dog and revealed only one potential canonical c-Myb binding site. Additional scanning of the GATA-3 promoter locus revealed 2 closely spaced potential c-Myb binding sites around nucleotide -1837 ( Figure 2C ).
Therefore, we carried out Dual Luciferase reporter assays with three GATA-3 promoter constructs of varying length and sequence ( Figure 2C c-Myb over-expression increased luciferase activity ~3.8 fold in human primary T cells cotransfected with pG3P-S, compared to when human primary T cells were co-transfected with empty vector (control) ( Figure 2D ). In contrast, when the luciferase reporter was driven by pG3P-M, the promoter with the mutated Myb binding site, luciferase activity increased only ~1.5 fold in the cells compared to the control. Curiously, pG3P-L did not have any greater affect on promoter activity than when pG3-S was co-transfected with c-Myb ( Figure 2D ). In aggregate, these results suggest that c-Myb activates the GATA-3 promoter in human primary T cells under We additionally determined the effect of silencing c-Myb on the activity of pG3P-S GATA-3 promoter in human T cells. A Dual-Luciferase assay was carried out using the methodology just described. We found that silencing c-Myb decreased pG3P-S reporter activity by ~50 % in the cells ( Figure 2E ). Since the transfection efficiency of the siRNA was only ~50% as well (data not shown), we considered this decrease significant.
GATA-3 and c-Myb act cooperatively to activate the GATA-3 promoter
Having established that c-Myb binds the GATA-3 promoter in developing Th2 cells, we next sought to develop a more complete understanding of how such binding is regulated. To begin to address this question, we carried out immunoprecipitation (IP) experiments using material derived from primary human naive CD4+ T cells stimulated under Th2 cell promoting conditions.
Since it is known that the IL-4/STAT6 pathway induces GATA-3 expression in naive CD4+ T cells, and that GATA-3 is essential for Th2 cell development 5, 22 , we examined whether c-Myb, STAT6, and/or GATA-3 itself interacted under Th2 cell promoting conditions. We found that while c-Myb and GATA-3 could be found in the same immunoprecipitated complex, STAT6
was not detected and therefore was not apparently incorporated into the c-Myb/GATA-3 complex ( Figure 3A ). Several reports have indicated that GATA-3 can regulate its own expression independent of IL-4 signaling and STAT6 activation [8] [9] [10] [11] . Since the results shown in Figure 3A suggested that c-Myb and GATA-3 were physically associated with each other, we wondered if c-Myb might be playing a role in GATA-3's ability to auto-activate its own expression? To address this question, we first sought to determine if c-Myb protein alone was sufficient to activate the GATA-3 promoter. We employed the Dual-Luciferase reporter assay, described immediately above in 293T cells since these cells express neither endogenous c-Myb, For personal use only. on November 16, 2017. by guest www.bloodjournal.org From nor GATA-3. The results revealed that c-Myb could activate the minimal GATA-3 promoter ~3 fold compared to a control vector in the absence of GATA-3, while co-expression of GATA-3 along with c-Myb increased luciferase activity ~5.4 fold ( Figure 3B ). Dose response studies suggested that once a threshold amount of c-Myb was present, increasing amounts did not further activate the promoter, alone, or in combination with GATA-3. In contrast, once c-Myb was expressed in the system, increasing amounts of GATA-3 lead to increasing amounts of luciferase activity, up to ~ 8 fold ( Figure 3B ). The results indicate that c-Myb alone can activate the GATA-3 promoter, but when combined with GATA-3 this capability is substantially enhanced.
To further explore c-Myb's contribution to activation of the GATA-3 promoter, we carried out a dual-luciferase reporter assay in 293T cells using the pG3P-M construct. Mutating the c-Myb binding site diminished the ability of GATA-3 and c-Myb to upregulate GATA-3 driven expression from the pG3P-S reporter plasmid in 293T cells again showing the cooperative nature of the interaction between these proteins ( Figure 3C ). This observation leads us to hypothesize that c-Myb plays an important role in the ability of GATA-3 to auto-activate its own promoter.
To better understand the physiologic relevance of the interaction between c-Myb and GATA-3 we performed similar reporter assays in human primary T cells, under Th2 cell promoting conditions, using the same c-Myb and GATA-3 expression constructs. We again observed an additive effect of c-Myb and GATA-3 on reporter activity ( Figure 3D ). Silencing c-Myb with siRNA decreased the promoter's activity in the presence of GATA-3, but only partially, compared to primary T cells co-transfected with GATA-3 and control siRNA ( Figure 3E ).
Assembling the c-Myb/GATA-3 complex on the GATA-3 promoter
To understand the nature of the c-Myb/GATA-3 interaction on a more mechanistic level, we sought to identify functional GATA binding site(s) within GATA-3's promoter and the effect of c-Myb on GATA-3's ability to bind to these sites. The ~735 nt GATA-3 minimal promoter of pG3P-S vector contains two possible well conserved GATA binding sites, CTTGATACTT and TCAGATTGCG 23 . To determine the functional importance of each GATA binding site in the promoter, we mutated each individually, or both sites simultaneously ( Figure 4A ), and then performed Dual-Luciferase reporter assays in the absence and presence of c-Myb and/or GATA-3. Mutating the individual GATA binding sites did not change the promoter activity. However, when both GATA binding sites were mutated simultaneously, the addition of GATA-3 to c-myb did not activate luciferase activity to a greater extent than c-Myb alone ( Figure 4B ). Taken together, these data indicate that the two GATA binding sites complement each other, and lead us to suggest that GATA-3 minimally requires one functional GATA binding site to activate its own promoter in the presence of c-Myb.
Having determined that GATA-3 and c-Myb act cooperatively to activate the GATA-3 promoter, we next sought to determine the nature of this interaction. In particular, we wished to know if GATA-3 was capable of binding its own promoter in the absence of c-Myb, or whether c-Myb needed to recruit GATA-3, either at the locus, or in the form of a pre-complex, in order for binding to take place. We therefore, silenced c-Myb in Jurkat cells using siRNA, and then performed ChIP assays with GATA-3 antibody. Since, as expected, GATA-3 expression decreased dramatically in Jurkat cells in which c-Myb was silenced, the amount of DNA that was immunoprecipitated by anti-GATA-3 decreased 90% compare to control siRNA ( Figure 4C , left For personal use only. on November 16, 2017. by guest www.bloodjournal.org From panel). Interestingly, when we rescued GATA-3 expression in the cells in which c-Myb had been silenced with an expression vector expressing Flag-tagged GATA-3 (pcDNA3 GATA-3-Flag), GATA-3 still did not bind to its own promoter in the absence of c-Myb. Therefore the ability of GATA-3 to bind to its own promoter is highly dependent on the expression of c-Myb.
c-Myb binds to GATA-3 through Menin.
We next asked whether the c-Myb/GATA-3 interaction required a co-factor, or was able to take place in the absence of a facilitating protein. To address this question, we in vitro translated c-Myb and GATA-3 individually, and then mixed both proteins in vitro to determine whether they could form a stable complex. Despite numerous repetitions, we were unable to demonstrate any direct interaction between c-Myb and GATA-3 (data not shown). Accordingly, since recent work from our laboratory has shown that c-Myb interacts with MLL [Mixed Lineage Leukemia] through the adapter protein Menin, a product of the MEN1 gene, in leukemic cells and stimulated human primary T cells 24 , we explored the possibility that Menin might serve as an adaptor protein for the c-Myb/GATA-3 protein association.
We first examined whether Menin was associated with c-Myb and GATA-3 in primary CD4+ T cells stimulated to undergo Th2 cell development. In such cells, immunoprecipitation revealed that Menin was associated with both c-Myb and GATA-3 ( Figure 5A ). Next, we evaluated whether Menin bound to c-Myb and GATA-3 directly by using in vitro synthesized proteins.
When the pure proteins were allowed to interact in a cell free solution, Menin protein was co- can see that the direct c-Myb-GATA-3 interaction is weak (lane 1), but in the presence of Menin (lane 2), the interaction is considerably strengthened and therefore much more easily observed in the Western blot. In aggregate, these findings strongly suggest that c-Myb binds to GATA-3 through Menin and that the interaction is at least partially inhibited by c-Myb's negative regulatory domain.
c-Myb, GATA-3 and Menin bind the GATA-3 promoter in CD4+ naive cells under Th2 cell promoting conditions, while MLL binds to the same promoter region with c-Myb, GATA-3 and Menin in CD4+ effector/memory cells.
Having established that the interaction between c-Myb, and GATA-3 is facilitated by Menin, and knowing that Menin also facilitates the interaction between c-Myb and MLL 24 , we carried out ChIP assays to determine if c-Myb and Menin played a role in the reported recruitment of MLL to the GATA-3 promoter locus 26, 27 , and if so, under what circumstances. We first performed a ChIP with CD4+ T cells stimulated for 3 days with IL-2, CD3/28 antibodies, and IL-4. CBP and p300 antibodies were also added to the ChIP reaction because of reports that these proteins function as c-Myb co-activator proteins 28,29 . The ChIP assays carried out with material from primary human CD4+ T cells stimulated under Th2 cell promoting conditions revealed that GATA-3, MLL and Menin bound to the GATA-3 promoter, but CBP and p300 did not under these experimental conditions ( Figure 6A ). Next, we evaluated protein binding to the GATA-3 promoter in CD4+ naïve and effector/memory T cells. We found that c-Myb, GATA-3 and Menin bound to the GATA-3 promoter, but MLL did not, in naïve CD4+ T cells stimulated with IL-2, IL-4 and CD3/CD28 antibodies ( Figure 6B ). In contrast, MLL bound to the promoter along with c-Myb, GATA-3 and Menin in effector/memory CD4+ T cells stimulated with IL-2, IL-4, and CD3/CD28 antibodies ( Figure 6C ). We found no evidence to support direct binding of GATA-3 to MLL by IP assays (data not shown). Therefore, we carried out a Re-ChIP assay to determine if MLL, Menin and GATA-3 associated in the same region of the GATA-3 promoter in effector/memory cells. The Re-ChIP assay with stimulated CD4+ effector/memory T cells showed that GATA-3 bound to the same locus in the GATA-3 promoter when precipitated with either MLL or Menin polyclonal antibodies ( Figure 6D ). c-Myb also bound in the same region.
However, neither GATA-3 nor c-Myb bound the locus where MLL antibody precipitated in naïve CD4+ T cells after 3 day stimulation under Th2 promoting condition ( Figure 6E ).
c-Myb silencing decreases the methylation of histone H3K4 and the acetylation of histone H3K9 at GATA-3 locus in Jurkat cells, and primary human CD4+ naive and effector/memory T cells when stimulated under Th2 promoting conditions.
We next examined whether c-Myb could influence histone modifications of the GATA-3 gene locus. To do this, we silenced c-Myb expression in Jurkat cells, as well as in primary human CD4+ CD45RA+ T cells, and CD4+ CD45RA-T cells stimulated under Th2 cell promoting conditions as described in the methods section. We then performed ChIP assays with antibodies directed to Histone H3 di-and tri-methylated K4, Histone H3 acetyl K9, Histone H3 dimethylated K9, and 20 primers pairs suggested by Primer3 (http://frodo.wi.mit.edu/primer3/) ( Supplementary Table S2 ) for sequences predicted to amplify well by QRT-PCR within the ~27kb GATA-3 locus. The ChIPs revealed that compared to control siRNA treated cells, silencing c-Myb led to decreased levels of H3K4 di-and tri-methylation, as well as H3K9 acetylation in the region of the GATA-3 promoter. These changes were observed in Jurkat cells, as well as in stimulated human CD4+ T lymphocytes where a bona fide c-Myb binding site is known to exist (Figure 7A , B, and C). Interestingly, histone changes were most marked in stimulated effector/memory CD4+ T lymphocytes ( Figure 7C ). Of note, silencing c-Myb did not affect the level of histone H3K9 di-methylation. In aggregate, these results demonstrate that c-Myb makes a significant contribution to chromatin re-modeling at the GATA-3 gene locus in human primary Th2 cells during their development, and as we interpret our data, in particular during their transition into memory cells.
Discussion
Using a variety of experimental techniques including transient gene silencing with oligonucleotides 30 , expression of dominant negative c-Myb protein 31, 32 , and tissue specific loss of floxed c-Myb in Cre-producing mouse strains [33] [34] [35] [36] it has been demonstrated unequivocally that c-Myb is important at multiple points during T cell development 7 Th2 cell differentiation is dependent on a regulated expression of the GATA-3 transcription factor 3 . In naive T cells, GATA-3 expression is detectable but very low. Upon binding IL-4, a STAT6 dependent signal transduction cascade is initiated that leads to the upregulation of GATA-3 expression 37 . We believe this initial upregulation is in fact a "priming" stimulus because thereafter GATA-3 levels increase dramatically, in what previous investigations have suggested is an IL-4/STAT6 independent event [8] [9] [10] [11] . The studies presented in this manuscript suggest that it is the formation of a highly active transcription complex composed minimally of Figures 1 and 2) . Since the binding of GATA-3 to its own promoter is required, we have further shown that GATA-3 upregulation is properly considered auto-regulatory in nature (Figures 3 and   4 ). Finally, we have also determined that while GATA-3 binding to its own promoter is required for the enhanced expression of GATA-3 during Th2 cell development, it is not by itself sufficient to induce the levels of GATA-3 that are observed during this process (Figure 3 ). Rather, our data demonstrate that GATA-3 is active within a transcriptional complex that contains c-Myb We noted with interest several reports which indicated that transcriptionally active proteins more usually associated with myelopoiesis also play important roles in lymphoid cell development. Specifically, this group reported that MLL(+/-) CD4+ T cells could differentiate normally into antigen-specific effector Th1/Th2 cells in vitro, but the ability of MLL(+/-) memory Th2 cells to produce Th2 cytokines was reduced. The reduced expression of MLL in memory Th2 cells was also associated with decreased GATA3 expression as well as impaired maintenance of GATA3 locus histone modifications. Since MLL, a member of the Trithorax gene family, functions as a histone methyl-transferase (HMT) for H3K4 42 this finding suggested that MLL was affecting local gene expression by epigenetic modification of the locus. Pertinent to this report, our group has recently found that c-Myb interacts with MLL in leukemic cells through Menin 24 . Menin, the product of the MEN1 gene mutated in familial multiple endocrine neoplasia type 1, is often found in MLL HMT complexes 42 and plays an important role as an adapter protein, along with LEDGF, in allowing functional MLL complexes to assemble 43 . We were further intrigued by several papers which reported that Menin is able to interact with a number of different partners affecting T cell development including NF-kB, JunD, and Smad3, as well as MLL 44,45 .
For these reasons, and the fact that we have recently shown that Menin recruits c-Myb into the MLL complex in human leukemia cells 24 , we investigated the possibility that Menin might also be involved in assembling the Myb-GATA3 transcription complex and found that this was indeed the case ( Figures 5 and 6) . Importantly, the c-Myb-Menin-MLL complexes were shown Effector/Memory CD4+ T 
